{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:58:27Z","timestamp":1794337107980,"version":"4.9.0"},"reference-count":224,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Therapeutic interventions to replenish lost cardiomyocytes and recover myocardium functions following ischemic myocardial infarction (MI) remain major goals in the cardiac regeneration field. Clinical trials harnessing autologous or allogeneic cell therapy approaches from both cardiac and noncardiac cells sources, thus far, demonstrate marginal improvement. Moreover, complications such as arrythmias and graft rejections associated with cellular or organ-based therapies continue to prevail. Extracellular vesicles, on the other hand, are cell-derived, nano-sized, cargo-containing biomolecules that have emerged as potent alternatives to cell-based cardiac regeneration\/replacement therapy. Recent studies demonstrate that most stem-cell-derived extracellular vesicles (Stem-EVs) are nonimmunogenic and carry cardioprotective therapeutic cargos. Moreover, administration of multiple Stem-EV types in animal models of acute MI results in reduced inflammation, apoptosis, smaller infarct size and improved cardiac functionality. With recent developments, engineered Stem-EVs with enhanced cardiac targeting, prolonged circulation and recombinant therapeutic cargos may tilt the cardiac regeneration field toward these novel cell-free biologics. Here we provide a brief overview of current approaches to repair and replenish damaged cardiomyocytes following MI via cell therapy and in vivo reprogramming, and we delve deeply into the therapeutic potentials of Stem-EVs in cardiac repair and regeneration.<\/jats:p>","DOI":"10.1038\/s12276-025-01549-3","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:28:28Z","timestamp":1759300108000},"page":"2182-2200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cardiac repair and regeneration: cell therapy, in vivo reprogramming, and the promise of extracellular vesicles"],"prefix":"10.1038","volume":"57","author":[{"given":"R. M. Imtiaz","family":"Karim Rony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"1549_CR1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","volume":"38","author":"M Urbich","year":"2020","unstructured":"Urbich, M. et al. A Systematic review of medical costs associated with heart failure in the USA (2014\u20132020). Pharmacoeconomics 38, 1219\u20131236 (2020).","journal-title":"Pharmacoeconomics"},{"key":"1549_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/fampra\/cmx040","volume":"34","author":"CJ Taylor","year":"2017","unstructured":"Taylor, C. J. et al. Survival following a diagnosis of heart failure in primary care. Fam. Pract. 34, 161\u2013168 (2017).","journal-title":"Fam. Pract."},{"key":"1549_CR3","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41591-023-02567-2","volume":"29","author":"CSP Lam","year":"2023","unstructured":"Lam, C. S. P. et al. Recent successes in heart failure treatment. Nat Med 29, 2424\u20132437 (2023).","journal-title":"Nat Med"},{"key":"1549_CR4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.119.045401","volume":"142","author":"NR Tucker","year":"2020","unstructured":"Tucker, N. R. et al. Transcriptional and cellular diversity of the human heart. Circulation 142, 466\u2013482 (2020).","journal-title":"Circulation"},{"key":"1549_CR5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","volume":"588","author":"M Litvinukova","year":"2020","unstructured":"Litvinukova, M. et al. Cells of the adult human heart. Nature 588, 466\u2013472 (2020).","journal-title":"Nature"},{"key":"1549_CR6","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","volume":"161","author":"O Bergmann","year":"2015","unstructured":"Bergmann, O. et al. Dynamics of cell generation and turnover in the human heart. Cell 161, 1566\u20131575 (2015).","journal-title":"Cell"},{"key":"1549_CR7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.5966\/sctm.2015-0118","volume":"4","author":"LR Collins","year":"2015","unstructured":"Collins, L. R., Priest, C., Caras, I., Littman, N. & Kadyk, L. Proceedings: moving toward cell-based therapies for heart disease. Stem Cells Transl Med 4, 863\u2013867 (2015).","journal-title":"Stem Cells Transl Med"},{"key":"1549_CR8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1200708","volume":"331","author":"ER Porrello","year":"2011","unstructured":"Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078\u20131080 (2011).","journal-title":"Science"},{"key":"1549_CR9","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.1408233111","volume":"111","author":"SR Ali","year":"2014","unstructured":"Ali, S. R. et al. Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice. Proc. Natl Acad. Sci. USA 111, 8850\u20138855 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1549_CR10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature11682","volume":"493","author":"SE Senyo","year":"2013","unstructured":"Senyo, S. E. et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433\u2013436 (2013).","journal-title":"Nature"},{"key":"1549_CR11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann, O. et al. Evidence for cardiomyocyte renewal in humans. Science 324, 98\u2013102 (2009).","journal-title":"Science"},{"key":"1549_CR12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrm3619","volume":"14","author":"M Xin","year":"2013","unstructured":"Xin, M., Olson, E. N. & Bassel-Duby, R. Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat. Rev. Mol. Cell Biol. 14, 529\u2013541 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1549_CR13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-018-0036-6","volume":"15","author":"H Hashimoto","year":"2018","unstructured":"Hashimoto, H., Olson, E. N. & Bassel-Duby, R. Therapeutic approaches for cardiac regeneration and repair. Nat. Rev. Cardiol. 15, 585\u2013600 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"1549_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2023.07.009","volume":"182","author":"A Pezhouman","year":"2023","unstructured":"Pezhouman, A. et al. Cardiac regeneration\u2014past advancements, current challenges, and future directions. J. Mol. Cell Cardiol. 182, 75\u201385 (2023).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1549_CR15","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/CIRCRESAHA.120.315855","volume":"126","author":"A Cannata","year":"2020","unstructured":"Cannata, A., Ali, H., Sinagra, G. & Giacca, M. Gene therapy for the heart lessons learned and future perspectives. Circ. Res. 126, 1394\u20131414 (2020).","journal-title":"Circ. Res."},{"key":"1549_CR16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","volume":"15","author":"P Menasche","year":"2018","unstructured":"Menasche, P. Cell therapy trials for heart regeneration\u2014lessons learned and future directions. Nat. Rev. Cardiol. 15, 659\u2013671 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"1549_CR17","doi-asserted-by":"crossref","unstructured":"Guo, Y., Yu, Y., Hu, S., Chen, Y. & Shen, Z. The therapeutic potential of mesenchymal stem cells for cardiovascular diseases. Cell Death Dis. 11 (2020).","DOI":"10.1038\/s41419-020-2542-9"},{"key":"1549_CR18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"Lai, R. C. et al. Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res. 4, 214\u2013222 (2010).","journal-title":"Stem Cell Res."},{"key":"1549_CR19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ebiom.2017.01.029","volume":"16","author":"R Duelen","year":"2017","unstructured":"Duelen, R. & Sampaolesi, M. Stem cell technology in cardiac regeneration: a pluripotent stem cell promise. EBioMedicine 16, 30\u201340 (2017).","journal-title":"EBioMedicine"},{"key":"1549_CR20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fbioe.2020.00455","volume":"8","author":"M Mazzola","year":"2020","unstructured":"Mazzola, M. & Di Pasquale, E. Toward Cardiac Regeneration: Combination of Pluripotent Stem Cell-Based Therapies and Bioengineering Strategies. Front. Bioeng. Biotechnol. 8, 455 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"1549_CR21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41569-019-0331-x","volume":"17","author":"E Karbassi","year":"2020","unstructured":"Karbassi, E. et al. Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine. Nat. Rev. Cardiol. 17, 341\u2013359 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"1549_CR22","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.119.315862","volume":"126","author":"Y Guo","year":"2020","unstructured":"Guo, Y. & Pu, W. T. Cardiomyocyte maturation: new phase in development. Circ. Res. 126, 1086\u20131106 (2020).","journal-title":"Circ. Res."},{"key":"1549_CR23","doi-asserted-by":"publisher","unstructured":"Bishop, S. P., Zhang, J. & Ye, L. Cardiomyocyte proliferation from fetal- to adult- and from normal- to hypertrophy and failing hearts. Biology https:\/\/doi.org\/10.3390\/biology11060880 (2022).","DOI":"10.3390\/biology11060880"},{"key":"1549_CR24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","volume":"510","author":"JJ Chong","year":"2014","unstructured":"Chong, J. J. et al. Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510, 273\u2013277 (2014).","journal-title":"Nature"},{"key":"1549_CR25","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","volume":"538","author":"Y Shiba","year":"2016","unstructured":"Shiba, Y. et al. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts. Nature 538, 388\u2013391 (2016).","journal-title":"Nature"},{"key":"1549_CR26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s44161-024-00472-6","volume":"3","author":"T Eschenhagen","year":"2024","unstructured":"Eschenhagen, T. & Weinberger, F. Challenges and perspectives of heart repair with pluripotent stem cell-derived cardiomyocytes. Nat. Cardiovasc. Res. 3, 515\u2013524 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1549_CR27","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.119.044974","volume":"143","author":"D El-Nachef","year":"2021","unstructured":"El-Nachef, D. et al. Engrafted human induced pluripotent stem cell-derived cardiomyocytes undergo clonal expansion in vivo. Circulation 143, 1635\u20131638 (2021).","journal-title":"Circulation"},{"key":"1549_CR28","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/s44161-023-00377-w","volume":"2","author":"Y Xie","year":"2023","unstructured":"Xie, Y., Van Handel, B., Qian, L. & Ardehali, R. Recent advances and future prospects in direct cardiac reprogramming. Nat. Cardiovasc. Res. 2, 1148\u20131158 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"1549_CR29","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1016\/j.celrep.2017.09.005","volume":"20","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y. et al. Comparative gene expression analyses reveal distinct molecular signatures between differentially reprogrammed cardiomyocytes. Cell Rep. 20, 3014\u20133024 (2017).","journal-title":"Cell Rep."},{"key":"1549_CR30","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-022-00410-w","volume":"21","author":"L Cheng","year":"2022","unstructured":"Cheng, L. & Hill, A. F. Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discov. 21, 379\u2013399, https:\/\/doi.org\/10.1038\/s41573-022-00410-w (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1549_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel, G., D\u2019Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213\u2013228 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1549_CR32","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"1549_CR33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/CIRCRESAHA.123.323054","volume":"135","author":"A Rai","year":"2024","unstructured":"Rai, A., Claridge, B., Lozano, J. & Greening, D. W. The discovery of extracellular vesicles and their emergence as a next-generation therapy. Circ. Res. 135, 198\u2013221 (2024).","journal-title":"Circ. Res."},{"key":"1549_CR34","doi-asserted-by":"publisher","unstructured":"Yin, L. et al. Therapeutic advances of stem cell-derived extracellular vesicles in regenerative medicine. Cells https:\/\/doi.org\/10.3390\/cells9030707 (2020).","DOI":"10.3390\/cells9030707"},{"key":"1549_CR35","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ehf2.13144","volume":"8","author":"D Jenca","year":"2021","unstructured":"Jenca, D. et al. Heart failure after myocardial infarction: incidence and predictors. ESC Heart Fail. 8, 222\u2013237 (2021).","journal-title":"ESC Heart Fail."},{"key":"1549_CR36","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1161\/ATVBAHA.119.312578","volume":"39","author":"J Palasubramaniam","year":"2019","unstructured":"Palasubramaniam, J., Wang, X. & Peter, K. Myocardial infarction-from atherosclerosis to thrombosis. Arterioscler. Thromb. Vasc. Biol. 39, e176\u2013e185 (2019).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1549_CR37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby, P. et al. Atherosclerosis. Nat. Rev. Dis. Primers 5, 56 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1549_CR38","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby, P. The changing landscape of atherosclerosis. Nature 592, 524\u2013533 (2021).","journal-title":"Nature"},{"key":"1549_CR39","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","volume":"185","author":"JLM Bjorkegren","year":"2022","unstructured":"Bjorkegren, J. L. M. & Lusis, A. J. Atherosclerosis: recent developments. Cell 185, 1630\u20131645 (2022).","journal-title":"Cell"},{"key":"1549_CR40","first-page":"241","volume":"102","author":"RB Jennings","year":"1981","unstructured":"Jennings, R. B. & Reimer, K. A. Lethal myocardial ischemic injury. Am. J. Pathol. 102, 241\u2013255 (1981).","journal-title":"Am. J. Pathol."},{"key":"1549_CR41","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch, G. Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat. Rev. Cardiol. 17, 773\u2013789, (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"1549_CR42","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.750510","volume":"8","author":"AM Lodrini","year":"2021","unstructured":"Lodrini, A. M. & Goumans, M. J. Cardiomyocytes cellular phenotypes after myocardial infarction. Front. Cardiovasc. Med. 8, 750510 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1549_CR43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002460","volume":"9","author":"Y Gerber","year":"2016","unstructured":"Gerber, Y. et al. Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circ. Heart Fail. 9, e002460 (2016).","journal-title":"Circ. Heart Fail."},{"key":"1549_CR44","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/CIRCRESAHA.124.323658","volume":"134","author":"I Hilgendorf","year":"2024","unstructured":"Hilgendorf, I., Frantz, S. & Frangogiannis, N. G. Repair of the infarcted heart: cellular effectors, molecular mechanisms and therapeutic opportunities. Circ. Res. 134, 1718\u20131751 (2024).","journal-title":"Circ. Res."},{"key":"1549_CR45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","volume":"119","author":"SD Prabhu","year":"2016","unstructured":"Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ. Res. 119, 91\u2013112 (2016).","journal-title":"Circ. Res."},{"key":"1549_CR46","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225","volume":"8","author":"T Nevers","year":"2015","unstructured":"Nevers, T. et al. Left ventricular T-cell recruitment contributes to the pathogenesis of heart failure. Circ. Heart Fail. 8, 776\u2013787 (2015).","journal-title":"Circ. Heart Fail."},{"key":"1549_CR47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev-immunol-042718-041717","volume":"38","author":"S Sakaguchi","year":"2020","unstructured":"Sakaguchi, S. et al. Regulatory T cells and human disease. Annu. Rev. Immunol. 38, 541\u2013566 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"1549_CR48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","volume":"56","author":"S Dikiy","year":"2023","unstructured":"Dikiy, S. & Rudensky, A. Y. Principles of regulatory T cell function. Immunity 56, 240\u2013255 (2023).","journal-title":"Immunity"},{"key":"1549_CR49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00395-011-0232-6","volume":"107","author":"TT Tang","year":"2012","unstructured":"Tang, T. T. et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res. Cardiol. 107, 232 (2012).","journal-title":"Basic Res. Cardiol."},{"key":"1549_CR50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","volume":"115","author":"J Weirather","year":"2014","unstructured":"Weirather, J. et al. Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation. Circ. Res. 115, 55\u201367 (2014).","journal-title":"Circ. Res."},{"key":"1549_CR51","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1161\/CIRCULATIONAHA.120.046789","volume":"142","author":"N Xia","year":"2020","unstructured":"Xia, N. et al. A unique population of regulatory T cells in heart potentiates cardiac protection from myocardial infarction. Circulation 142, 1956\u20131973 (2020).","journal-title":"Circulation"},{"key":"1549_CR52","volume":"9","author":"J Wang","year":"2022","unstructured":"Wang, J., An, M., Haubner, B. J. & Penninger, J. M. Cardiac regeneration: options for repairing the injured heart. Front. Cardiovasc. Med. 9, 981982 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"1549_CR53","doi-asserted-by":"publisher","unstructured":"Tsai, I. T. & Sun, C. K. Stem cell therapy against ischemic heart disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms25073778 (2024).","DOI":"10.3390\/ijms25073778"},{"key":"1549_CR54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(00)03617-5","volume":"357","author":"P Menasche","year":"2001","unstructured":"Menasche, P. et al. Myoblast transplantation for heart failure. Lancet 357, 279\u2013280 (2001).","journal-title":"Lancet"},{"key":"1549_CR55","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","volume":"117","author":"P Menasche","year":"2008","unstructured":"Menasche, P. et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117, 1189\u20131200 (2008).","journal-title":"Circulation"},{"key":"1549_CR56","doi-asserted-by":"crossref","first-page":"I101","DOI":"10.1161\/CIRCULATIONAHA.105.000505","volume":"114","author":"M Hendrikx","year":"2006","unstructured":"Hendrikx, M. et al. Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 114, I101\u2013I107 (2006).","journal-title":"Circulation"},{"key":"1549_CR57","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","volume":"307","author":"EC Perin","year":"2012","unstructured":"Perin, E. C. et al. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial. JAMA 307, 1717\u20131726 (2012).","journal-title":"JAMA"},{"key":"1549_CR58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman, A. W. et al. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 311, 62\u201373 (2014).","journal-title":"JAMA"},{"key":"1549_CR59","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","volume":"94","author":"SL Chen","year":"2004","unstructured":"Chen, S. L. et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am. J. Cardiol. 94, 92\u201395 (2004).","journal-title":"Am. J. Cardiol."},{"key":"1549_CR60","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JM Hare","year":"2009","unstructured":"Hare, J. M. et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277\u20132286 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1549_CR61","volume":"12","author":"SA Fisher","year":"2016","unstructured":"Fisher, S. A., Doree, C., Mathur, A., Taggart, D. P. & Martin-Rendon, E. Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. Cochrane Database Syst. Rev. 12, CD007888 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"1549_CR62","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jtcvs.2006.08.077","volume":"133","author":"C Stamm","year":"2007","unstructured":"Stamm, C. et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J. Thorac. Cardiovasc. Surg. 133, 717\u2013725 (2007).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1549_CR63","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/eurheartj\/ehu007","volume":"35","author":"BA Nasseri","year":"2014","unstructured":"Nasseri, B. A. et al. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial. Eur. Heart J. 35, 1263\u20131274 (2014).","journal-title":"Eur. Heart J."},{"key":"1549_CR64","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","volume":"71","author":"P Menasche","year":"2018","unstructured":"Menasche, P. et al. Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J. Am. Coll. Cardiol. 71, 429\u2013438 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1549_CR65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tcm.2020.01.002","volume":"31","author":"JC Garbern","year":"2021","unstructured":"Garbern, J. C., Escalante, G. O. & Lee, R. T. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. Trends Cardiovasc. Med. 31, 85\u201390 (2021).","journal-title":"Trends Cardiovasc. Med."},{"key":"1549_CR66","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ebiom.2016.01.021","volume":"4","author":"JD Tompkins","year":"2016","unstructured":"Tompkins, J. D. et al. Mapping human pluripotent-to-cardiomyocyte differentiation: methylomes, transcriptomes, and exon DNA methylation \u201cmemories. EBioMedicine 4, 74\u201385 (2016).","journal-title":"EBioMedicine"},{"key":"1549_CR67","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1634\/stemcells.2006-0466","volume":"25","author":"L Sartiani","year":"2007","unstructured":"Sartiani, L. et al. Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach. Stem Cells 25, 1136\u20131144 (2007).","journal-title":"Stem Cells"},{"key":"1549_CR68","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.bbrc.2018.03.198","volume":"499","author":"TP Dias","year":"2018","unstructured":"Dias, T. P. et al. Biophysical study of human induced pluripotent stem cell-derived cardiomyocyte structural maturation during long-term culture. Biochem Biophys Res Commun 499, 611\u2013617 (2018).","journal-title":"Biochem Biophys Res Commun"},{"key":"1549_CR69","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.121.053563","volume":"145","author":"W Dhahri","year":"2022","unstructured":"Dhahri, W. et al. In vitro matured human pluripotent stem cell-derived cardiomyocytes form grafts with enhanced structure and function in injured hearts. Circulation 145, 1412\u20131426 (2022).","journal-title":"Circulation"},{"key":"1549_CR70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63905-z","volume":"14","author":"Z Iwon","year":"2024","unstructured":"Iwon, Z. et al. Maturation of human cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) on polycaprolactone and polyurethane nanofibrous mats. Sci. Rep. 14, 12975 (2024).","journal-title":"Sci. Rep."},{"key":"1549_CR71","doi-asserted-by":"publisher","unstructured":"Nakano, H. et al. Glucose inhibits cardiac muscle maturation through nucleotide biosynthesis. eLife https:\/\/doi.org\/10.7554\/eLife.29330 (2017).","DOI":"10.7554\/eLife.29330"},{"key":"1549_CR72","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.stemcr.2019.08.013","volume":"13","author":"X Yang","year":"2019","unstructured":"Yang, X. et al. Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cell Rep. 13, 657\u2013668 (2019).","journal-title":"Stem Cell Rep."},{"key":"1549_CR73","volume":"7","author":"G Eng","year":"2016","unstructured":"Eng, G. et al. Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes. Nat. Commun. 7, 10312 (2016).","journal-title":"Nat. Commun."},{"key":"1549_CR74","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s42003-020-0853-0","volume":"3","author":"J Li","year":"2020","unstructured":"Li, J. et al. Circulating re-entrant waves promote maturation of hiPSC-derived cardiomyocytes in self-organized tissue ring. Commun Biol 3, 122 (2020).","journal-title":"Commun Biol"},{"key":"1549_CR75","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biomaterials.2016.09.024","volume":"111","author":"CP Jackman","year":"2016","unstructured":"Jackman, C. P., Carlson, A. L. & Bursac, N. Dynamic culture yields engineered myocardium with near-adult functional output. Biomaterials 111, 66\u201379 (2016).","journal-title":"Biomaterials"},{"key":"1549_CR76","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","volume":"134","author":"JL Ruan","year":"2016","unstructured":"Ruan, J. L. et al. Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue. Circulation 134, 1557\u20131567 (2016).","journal-title":"Circulation"},{"key":"1549_CR77","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23329-z","volume":"12","author":"S Funakoshi","year":"2021","unstructured":"Funakoshi, S. et al. Generation of mature compact ventricular cardiomyocytes from human pluripotent stem cells. Nat. Commun. 12, 3155 (2021).","journal-title":"Nat. Commun."},{"key":"1549_CR78","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68373-9","volume":"10","author":"H Ichimura","year":"2020","unstructured":"Ichimura, H. et al. Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo. Sci. Rep. 10, 11883 (2020).","journal-title":"Sci. Rep."},{"key":"1549_CR79","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41569-021-00603-7","volume":"19","author":"M Yadid","year":"2022","unstructured":"Yadid, M., Oved, H., Silberman, E. & Dvir, T. Bioengineering approaches to treat the failing heart: from cell biology to 3D printing. Nat. Rev. Cardiol. 19, 83\u201399 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"1549_CR80","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1146\/annurev-cellbio-100818-125127","volume":"35","author":"B Aydin","year":"2019","unstructured":"Aydin, B. & Mazzoni, E. O. Cell reprogramming: the many roads to success. Annu. Rev. Cell Dev. Biol. 35, 433\u2013452, https:\/\/doi.org\/10.1146\/annurev-cellbio-100818-125127 (2019).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"1549_CR81","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41580-021-00335-z","volume":"22","author":"H Wang","year":"2021","unstructured":"Wang, H., Yang, Y., Liu, J. & Qian, L. Direct cell reprogramming: approaches, mechanisms and progress. Nat. Rev. Mol. Cell Biol. 22, 410\u2013424(2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1549_CR82","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.cell.2016.11.052","volume":"167","author":"A Ocampo","year":"2016","unstructured":"Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, 1719\u20131733 e1712 (2016).","journal-title":"Cell"},{"key":"1549_CR83","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.abg5159","volume":"373","author":"Y Chen","year":"2021","unstructured":"Chen, Y. et al. Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice. Science 373, 1537\u20131540 (2021).","journal-title":"Science"},{"key":"1549_CR84","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","volume":"14","author":"MD Tallquist","year":"2017","unstructured":"Tallquist, M. D. & Molkentin, J. D. Redefining the identity of cardiac fibroblasts. Nat. Rev. Cardiol. 14, 484\u2013491 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"1549_CR85","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","volume":"142","author":"M Ieda","year":"2010","unstructured":"Ieda, M. et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375\u2013386 (2010).","journal-title":"Cell"},{"key":"1549_CR86","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","volume":"485","author":"K Song","year":"2012","unstructured":"Song, K. et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485, 599\u2013604 (2012).","journal-title":"Nature"},{"key":"1549_CR87","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.stemcr.2013.07.005","volume":"1","author":"JD Fu","year":"2013","unstructured":"Fu, J. D. et al. Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state. Stem Cell Reports 1, 235\u2013247 (2013).","journal-title":"Stem Cell Reports"},{"key":"1549_CR88","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.1304053110","volume":"110","author":"R Wada","year":"2013","unstructured":"Wada, R. et al. Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. Proc. Natl Acad. Sci. USA 110, 12667\u201312672 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1549_CR89","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/cr.2015.99","volume":"25","author":"Y Fu","year":"2015","unstructured":"Fu, Y. et al. Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails. Cell Res. 25, 1013\u20131024 (2015).","journal-title":"Cell Res."},{"key":"1549_CR90","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.aaf1502","volume":"352","author":"N Cao","year":"2016","unstructured":"Cao, N. et al. Conversion of human fibroblasts into functional cardiomyocytes by small molecules. Science 352, 1216\u20131220 (2016).","journal-title":"Science"},{"key":"1549_CR91","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","volume":"121","author":"A Tachibana","year":"2017","unstructured":"Tachibana, A. et al. Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium. Circ. Res. 121, e22\u2013e36 (2017).","journal-title":"Circ. Res."},{"key":"1549_CR92","doi-asserted-by":"publisher","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science https:\/\/doi.org\/10.1126\/science.aau6977 (2020).","DOI":"10.1126\/science.aau6977"},{"key":"1549_CR93","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s42003-024-06938-4","volume":"7","author":"MJ Jeyarajah","year":"2024","unstructured":"Jeyarajah, M. J. et al. Placental extracellular vesicles promote cardiomyocyte maturation and fetal heart development. Commun. Biol. 7, 1254 (2024).","journal-title":"Commun. Biol."},{"key":"1549_CR94","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/CIRCRESAHA.117.311326","volume":"123","author":"X Loyer","year":"2018","unstructured":"Loyer, X. et al. Intra-cardiac release of extracellular vesicles shapes inflammation following myocardial infarction. Circ. Res. 123, 100\u2013106 (2018).","journal-title":"Circ. Res."},{"key":"1549_CR95","doi-asserted-by":"publisher","unstructured":"Saludas, L. et al. Extracellular vesicle-based therapeutics for heart repair. Nanomaterials https:\/\/doi.org\/10.3390\/nano11030570 (2021).","DOI":"10.3390\/nano11030570"},{"key":"1549_CR96","doi-asserted-by":"crossref","first-page":"H1749","DOI":"10.1152\/ajpheart.00925.2020","volume":"320","author":"S Saheera","year":"2021","unstructured":"Saheera, S., Jani, V. P., Witwer, K. W. & Kutty, S. Extracellular vesicle interplay in cardiovascular pathophysiology. Am. J. Physiol. Heart Circ. Physiol. 320, H1749\u2013H1761 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1549_CR97","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.767488","volume":"8","author":"AS Jadli","year":"2021","unstructured":"Jadli, A. S., Parasor, A., Gomes, K. P., Shandilya, R. & Patel, V. B. Exosomes in cardiovascular diseases: pathological potential of nano-messenger. Front. Cardiovasc. Med. 8, 767488 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"1549_CR98","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/biom15071000","volume":"15","author":"RMIK Rony","year":"2025","unstructured":"Rony, R. M. I. K. et al. Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease. Biomolecules 15, 1000 (2025).","journal-title":"Biomolecules"},{"key":"1549_CR99","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41551-018-0229-7","volume":"2","author":"B Liu","year":"2018","unstructured":"Liu, B. et al. Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat. Biomed. Eng. 2, 293\u2013303 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"1549_CR100","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12445","volume":"13","author":"H Gonzalez-King","year":"2024","unstructured":"Gonzalez-King, H. et al. Head-to-head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells. J. Extracell. Vesicles 13, e12445 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"1549_CR101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.healun.2023.08.011","volume":"43","author":"Y Tominaga","year":"2024","unstructured":"Tominaga, Y. et al. Pleiotropic effects of extracellular vesicles from induced pluripotent stem cell-derived cardiomyocytes on ischemic cardiomyopathy: a preclinical study. J. Heart Lung Transplant 43, 85\u201399 (2024).","journal-title":"J. Heart Lung Transplant"},{"key":"1549_CR102","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014345","volume":"9","author":"MR Santoso","year":"2020","unstructured":"Santoso, M. R. et al. Exosomes from induced pluripotent stem cell-derived cardiomyocytes promote autophagy for myocardial repair. J. Am. Heart Assoc. 9, e014345 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"1549_CR103","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3389\/fphys.2018.01794","volume":"9","author":"JA Dougherty","year":"2018","unstructured":"Dougherty, J. A. et al. Extracellular vesicles released by human induced-pluripotent stem cell-derived cardiomyocytes promote angiogenesis. Front. Physiol. 9, 1794 (2018).","journal-title":"Front. Physiol."},{"key":"1549_CR104","doi-asserted-by":"publisher","unstructured":"Gao, L. et al. Exosomes secreted by hiPSC-derived cardiac cells improve recovery from myocardial infarction in swine. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aay1318 (2020).","DOI":"10.1126\/scitranslmed.aay1318"},{"key":"1549_CR105","doi-asserted-by":"crossref","first-page":"H954","DOI":"10.1152\/ajpheart.00463.2020","volume":"320","author":"A Turner","year":"2021","unstructured":"Turner, A. et al. Donor-specific phenotypic variation in hiPSC cardiomyocyte-derived exosomes impacts endothelial cell function. Am. J. Physiol. Heart Circ. Physiol. 320, H954\u2013H968 (2021).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1549_CR106","volume":"11","author":"H Yu","year":"2020","unstructured":"Yu, H., Qin, L., Peng, Y., Bai, W. & Wang, Z. Exosomes derived from hypertrophic cardiomyocytes induce inflammation in macrophages via miR-155 mediated MAPK pathway. Front. Immunol. 11, 606045 (2020).","journal-title":"Front. Immunol."},{"key":"1549_CR107","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","volume":"115","author":"RR Smith","year":"2007","unstructured":"Smith, R. R. et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 115, 896\u2013908 (2007).","journal-title":"Circulation"},{"key":"1549_CR108","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AG Ibrahim","year":"2014","unstructured":"Ibrahim, A. G., Cheng, K. & Marban, E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem. Cell Rep. 2, 606\u2013619 (2014).","journal-title":"Stem. Cell Rep."},{"key":"1549_CR109","first-page":"201","volume":"38","author":"R Gallet","year":"2017","unstructured":"Gallet, R. et al. Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur. Heart J. 38, 201\u2013211 (2017).","journal-title":"Eur. Heart J."},{"key":"1549_CR110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-87939-9","volume":"11","author":"AS Walravens","year":"2021","unstructured":"Walravens, A. S. et al. Mechanistic and therapeutic distinctions between cardiosphere-derived cell and mesenchymal stem cell extracellular vesicle non-coding RNA. Sci. Rep. 11, 8666 (2021).","journal-title":"Sci. Rep."},{"key":"1549_CR111","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.116.024590","volume":"136","author":"G de Couto","year":"2017","unstructured":"de Couto, G. et al. Exosomal microRNA transfer into macrophages mediates cellular postconditioning. Circulation 136, 200\u2013214 (2017).","journal-title":"Circulation"},{"key":"1549_CR112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fcell.2020.00321","volume":"8","author":"E Lopez","year":"2020","unstructured":"Lopez, E. et al. The immunomodulatory signature of extracellular vesicles from cardiosphere-derived cells: a proteomic and miRNA profiling. Front. Cell Dev. Biol. 8, 321 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1549_CR113","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12178","volume":"11","author":"A Ciullo","year":"2022","unstructured":"Ciullo, A. et al. Biodistribution of unmodified cardiosphere-derived cell extracellular vesicles using single RNA tracing. J Extracell. Vesicles 11, e12178 (2022).","journal-title":"J Extracell. Vesicles"},{"key":"1549_CR114","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1002\/jcb.26621","volume":"119","author":"H Namazi","year":"2018","unstructured":"Namazi, H. et al. Exosomes secreted by hypoxic cardiosphere-derived cells enhance tube formation and increase pro-angiogenic miRNA. J. Cell Biochem. 119, 4150\u20134160 (2018).","journal-title":"J. Cell Biochem."},{"key":"1549_CR115","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbrc.2013.01.015","volume":"431","author":"L Chen","year":"2013","unstructured":"Chen, L. et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia\/reperfusion injury. Biochem. Biophys. Res. Commun. 431, 566\u2013571 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1549_CR116","doi-asserted-by":"crossref","first-page":"e0227283","DOI":"10.1371\/journal.pone.0227283","volume":"14","author":"P van den Hoogen","year":"2019","unstructured":"van den Hoogen, P. et al. Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure. PLoS ONE 14, e0227283 (2019).","journal-title":"PLoS ONE"},{"key":"1549_CR117","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00642","volume":"4","author":"F van den Akker","year":"2018","unstructured":"van den Akker, F. et al. Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles. Heliyon 4, e00642 (2018).","journal-title":"Heliyon"},{"key":"1549_CR118","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","volume":"103","author":"L Barile","year":"2014","unstructured":"Barile, L. et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res 103, 530\u2013541 (2014).","journal-title":"Cardiovasc Res"},{"key":"1549_CR119","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/eurheartj\/ehad636","volume":"45","author":"MY Emmert","year":"2024","unstructured":"Emmert, M. Y. et al. Intracoronary delivery of extracellular vesicles from human cardiac progenitor cells reduces infarct size in porcine acute myocardial infarction. Eur. Heart J. 45, 728\u2013732 (2024).","journal-title":"Eur. Heart J."},{"key":"1549_CR120","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/CIRCRESAHA.116.309782","volume":"120","author":"S Sharma","year":"2017","unstructured":"Sharma, S. et al. A deep proteome analysis identifies the complete secretome as the functional unit of human cardiac progenitor cells. Circ. Res. 120, 816\u2013834 (2017).","journal-title":"Circ. Res."},{"key":"1549_CR121","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","volume":"116","author":"WD Gray","year":"2015","unstructured":"Gray, W. D. et al. Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ. Res. 116, 255\u2013263 (2015).","journal-title":"Circ. Res."},{"key":"1549_CR122","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fcell.2020.00130","volume":"8","author":"JA Dougherty","year":"2020","unstructured":"Dougherty, J. A. et al. Human cardiac progenitor cells enhance exosome release and promote angiogenesis under physoxia. Front. Cell Dev. Biol. 8, 130 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"1549_CR123","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/SHK.0000000000001133","volume":"50","author":"W Xuan","year":"2018","unstructured":"Xuan, W. et al. Cardiac progenitors induced from human induced pluripotent stem cells with cardiogenic small molecule effectively regenerate infarcted hearts and attenuate fibrosis. Shock 50, 627\u2013639 (2018).","journal-title":"Shock"},{"key":"1549_CR124","volume":"2019","author":"W Xuan","year":"2019","unstructured":"Xuan, W., Wang, L., Xu, M., Weintraub, N. L. & Ashraf, M. miRNAs in extracellular vesicles from iPS-derived cardiac progenitor cells effectively reduce fibrosis and promote angiogenesis in infarcted heart. Stem Cell Int. 2019, 3726392 (2019).","journal-title":"Stem Cell Int."},{"key":"1549_CR125","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1206279","volume":"10","author":"M Desgres","year":"2023","unstructured":"Desgres, M. et al. Therapeutic potential of extracellular vesicles derived from cardiac progenitor cells in rodent models of chemotherapy-induced cardiomyopathy. Front. Cardiovasc. Med. 10, 1206279 (2023).","journal-title":"Front. Cardiovasc. Med."},{"key":"1549_CR126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105145","volume":"103","author":"P Menasche","year":"2024","unstructured":"Menasche, P. et al. First-in-man use of a cardiovascular cell-derived secretome in heart failure. Case report. EBioMedicine 103, 105145 (2024).","journal-title":"EBioMedicine"},{"key":"1549_CR127","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger, M. F. et al. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen. Med. 4, 22 (2019).","journal-title":"NPJ Regen. Med."},{"key":"1549_CR128","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/j.stemcr.2021.05.003","volume":"16","author":"SJ Sun","year":"2021","unstructured":"Sun, S. J., Wei, R., Li, F., Liao, S. Y. & Tse, H. F. Mesenchymal stromal cell-derived exosomes in cardiac regeneration and repair. Stem Cell Rep. 16, 1662\u20131673 (2021).","journal-title":"Stem Cell Rep."},{"key":"1549_CR129","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12265-021-10168-y","volume":"15","author":"H Meng","year":"2022","unstructured":"Meng, H. et al. Mesenchymal stem cell exosomes in the treatment of myocardial infarction: a systematic review of preclinical in vivo studies. J. Cardiovasc. Transl. Res. 15, 317\u2013339 (2022).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"1549_CR130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1161\/CIRCRESAHA.118.312758","volume":"123","author":"C Xiao","year":"2018","unstructured":"Xiao, C. et al. Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b. Circ. Res. 123, 564\u2013578 (2018).","journal-title":"Circ. Res."},{"key":"1549_CR131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.scr.2013.01.002","volume":"10","author":"F Arslan","year":"2013","unstructured":"Arslan, F. et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K\/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia\/reperfusion injury. Stem Cell Res. 10, 301\u2013312 (2013).","journal-title":"Stem Cell Res."},{"key":"1549_CR132","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/jcb.27399","volume":"121","author":"H Xu","year":"2020","unstructured":"Xu, H., Wang, Z., Liu, L., Zhang, B. & Li, B. Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction. J. Cell Biochem. 121, 2089\u20132102 (2020).","journal-title":"J. Cell Biochem."},{"key":"1549_CR133","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yjmcc.2018.04.012","volume":"119","author":"KM Luther","year":"2018","unstructured":"Luther, K. M. et al. Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells. J. Mol. Cell Cardiol. 119, 125\u2013137 (2018).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1549_CR134","volume":"11","author":"Y Peng","year":"2020","unstructured":"Peng, Y., Zhao, J. L., Peng, Z. Y., Xu, W. F. & Yu, G. L. Exosomal miR-25-3p from mesenchymal stem cells alleviates myocardial infarction by targeting pro-apoptotic proteins and EZH2. Cell Death Dis. 11, 317 (2020).","journal-title":"Cell Death Dis."},{"key":"1549_CR135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41420-022-00909-6","volume":"8","author":"R Yue","year":"2022","unstructured":"Yue, R. et al. Mesenchymal stem cell-derived exosomal microRNA-182-5p alleviates myocardial ischemia\/reperfusion injury by targeting GSDMD in mice. Cell Death Discov. 8, 202 (2022).","journal-title":"Cell Death Discov."},{"key":"1549_CR136","doi-asserted-by":"crossref","DOI":"10.1080\/15476278.2024.2356341","volume":"20","author":"S Wang","year":"2024","unstructured":"Wang, S., Wu, R., Chen, Q., Liu, T. & Li, L. Exosomes derived from TNF-alpha-treated bone marrow mesenchymal stem cells ameliorate myocardial infarction injury in mice. Organogenesis 20, 2356341 (2024).","journal-title":"Organogenesis"},{"key":"1549_CR137","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1007\/s12035-024-04056-0","volume":"61","author":"Q Wu","year":"2024","unstructured":"Wu, Q. et al. Exosomes from hypoxia-treated mesenchymal stem cells: promoting neuroprotection in ischemic stroke through miR-214-3p\/PTEN mechanism. Mol. Neurobiol. 61, 7611\u20137626 (2024).","journal-title":"Mol. Neurobiol."},{"key":"1549_CR138","first-page":"1659","volume":"46","author":"J Zhu","year":"2018","unstructured":"Zhu, J. et al. Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way. Artif. Cell Nanomed. Biotechnol. 46, 1659\u20131670 (2018).","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"key":"1549_CR139","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCRESAHA.111.253286","volume":"109","author":"S Sahoo","year":"2011","unstructured":"Sahoo, S. et al. Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity. Circ. Res. 109, 724\u2013728 (2011).","journal-title":"Circ. Res."},{"key":"1549_CR140","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1161\/CIRCRESAHA.116.310557","volume":"120","author":"P Mathiyalagan","year":"2017","unstructured":"Mathiyalagan, P. et al. Angiogenic mechanisms of human CD34+ stem cell exosomes in the repair of ischemic hindlimb. Circ. Res. 120, 1466\u20131476 (2017).","journal-title":"Circ. Res."},{"key":"1549_CR141","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","volume":"282","author":"JA Thomson","year":"1998","unstructured":"Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145\u20131147 (1998).","journal-title":"Science"},{"key":"1549_CR142","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676, https:\/\/doi.org\/10.1016\/j.cell.2006.07.024 (2006).","journal-title":"Cell"},{"key":"1549_CR143","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872, https:\/\/doi.org\/10.1016\/j.cell.2007.11.019 (2007).","journal-title":"Cell"},{"key":"1549_CR144","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ymthe.2018.02.026","volume":"26","author":"A Oikonomopoulos","year":"2018","unstructured":"Oikonomopoulos, A., Kitani, T. & Wu, J. C. Pluripotent stem cell-derived cardiomyocytes as a platform for cell therapy applications: progress and hurdles for clinical translation. Mol. Ther. 26, 1624\u20131634 (2018).","journal-title":"Mol. Ther."},{"key":"1549_CR145","doi-asserted-by":"crossref","first-page":"e4722","DOI":"10.1371\/journal.pone.0004722","volume":"4","author":"A Yuan","year":"2009","unstructured":"Yuan, A. et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE 4, e4722 (2009).","journal-title":"PLoS ONE"},{"key":"1549_CR146","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1002\/stem.2078","volume":"33","author":"S Bobis-Wozowicz","year":"2015","unstructured":"Bobis-Wozowicz, S. et al. Human induced pluripotent stem cell-derived microvesicles transmit RNAs and proteins to recipient mature heart cells modulating cell fate and behavior. Stem Cell 33, 2748\u20132761 (2015).","journal-title":"Stem Cell"},{"key":"1549_CR147","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/acsnano.1c00672","volume":"15","author":"Y Xia","year":"2021","unstructured":"Xia, Y. et al. Embryonic stem cell derived small extracellular vesicles modulate regulatory T cells to protect against ischemic stroke. ACS Nano 15, 7370\u20137385 (2021).","journal-title":"ACS Nano"},{"key":"1549_CR148","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijcard.2015.05.020","volume":"192","author":"Y Wang","year":"2015","unstructured":"Wang, Y. et al. Exosomes\/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int. J. Cardiol. 192, 61\u201369 (2015).","journal-title":"Int. J. Cardiol."},{"key":"1549_CR149","doi-asserted-by":"crossref","first-page":"29514","DOI":"10.1074\/jbc.M109.027896","volume":"284","author":"S Dong","year":"2009","unstructured":"Dong, S. et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J. Biol. Chem. 284, 29514\u201329525 (2009).","journal-title":"J. Biol. Chem."},{"key":"1549_CR150","first-page":"S124","volume":"122","author":"S Hu","year":"2010","unstructured":"Hu, S. et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation 122, S124\u2013S131 (2010).","journal-title":"Circulation"},{"key":"1549_CR151","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.117.305990","volume":"117","author":"M Khan","year":"2015","unstructured":"Khan, M. et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction. Circ. Res. 117, 52\u201364 (2015).","journal-title":"Circ. Res."},{"key":"1549_CR152","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCRESAHA.117.311769","volume":"122","author":"M Adamiak","year":"2018","unstructured":"Adamiak, M. et al. Induced pluripotent stem cell (iPSC)-derived extracellular vesicles are safer and more effective for cardiac repair than iPSCs. Circ. Res. 122, 296\u2013309 (2018).","journal-title":"Circ. Res."},{"key":"1549_CR153","volume":"21","author":"M Paw","year":"2023","unstructured":"Paw, M. et al. Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p\/TGFbeta\/SMAD2 axis. BMC Med. 21, 412 (2023).","journal-title":"BMC Med."},{"key":"1549_CR154","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-024-01722-7","volume":"22","author":"S Bobis-Wozowicz","year":"2024","unstructured":"Bobis-Wozowicz, S. et al. Hypoxic extracellular vesicles from hiPSCs protect cardiomyocytes from oxidative damage by transferring antioxidant proteins and enhancing Akt\/Erk\/NRF2 signaling. Cell Commun. Signal 22, 356 (2024).","journal-title":"Cell Commun. Signal"},{"key":"1549_CR155","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature20173","volume":"541","author":"Y Nakada","year":"2017","unstructured":"Nakada, Y. et al. Hypoxia induces heart regeneration in adult mice. Nature 541, 222\u2013227 (2017).","journal-title":"Nature"},{"key":"1549_CR156","doi-asserted-by":"crossref","first-page":"12544","DOI":"10.1073\/pnas.1209620109","volume":"109","author":"JD Tompkins","year":"2012","unstructured":"Tompkins, J. D. et al. Epigenetic stability, adaptability, and reversibility in human embryonic stem cells. Proc. Natl Acad. Sci. USA 109, 12544\u201312549 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1549_CR157","volume":"9","author":"X Li","year":"2018","unstructured":"Li, X. et al. A fully defined static suspension culture system for large-scale human embryonic stem cell production. Cell Death Dis. 9, 892 (2018).","journal-title":"Cell Death Dis."},{"key":"1549_CR158","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.omtm.2018.05.006","volume":"10","author":"R Tirughana","year":"2018","unstructured":"Tirughana, R. et al. GMP production and scale-up of adherent neural stem cells with a quantum cell expansion system. Mol. Ther. Methods Clin. Dev. 10, 48\u201356 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1549_CR159","first-page":"e1076","volume":"12","author":"CK Kwok","year":"2018","unstructured":"Kwok, C. K. et al. Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single-use bioreactors. J. Tissue Eng. Regen. Med. 12, e1076\u2013e1087 (2018).","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"1549_CR160","doi-asserted-by":"publisher","unstructured":"Ganeeva, I. et al. Recent advances in the development of bioreactors for manufacturing of adoptive cell immunotherapies. Bioengineering https:\/\/doi.org\/10.3390\/bioengineering9120808 (2022).","DOI":"10.3390\/bioengineering9120808"},{"key":"1549_CR161","volume":"8","author":"SC Nath","year":"2020","unstructured":"Nath, S. C., Harper, L. & Rancourt, D. E. Cell-based therapy manufacturing in stirred suspension bioreactor: thoughts for cGMP compliance. Front. Bioeng. Biotechnol. 8, 599674 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"1549_CR162","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3389\/fphar.2018.01199","volume":"9","author":"GD Kusuma","year":"2018","unstructured":"Kusuma, G. D. et al. To protect and to preserve: novel preservation strategies for extracellular vesicles. Front. Pharmacol. 9, 1199 (2018).","journal-title":"Front. Pharmacol."},{"key":"1549_CR163","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12238","volume":"11","author":"A Gorgens","year":"2022","unstructured":"Gorgens, A. et al. Identification of storage conditions stabilizing extracellular vesicles preparations. J. Extracell. Vesicles 11, e12238 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"1549_CR164","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2022.151227","volume":"101","author":"M Clos-Sansalvador","year":"2022","unstructured":"Clos-Sansalvador, M., Monguio-Tortajada, M., Roura, S., Franquesa, M. & Borras, F. E. Commonly used methods for extracellular vesicles\u2019 enrichment: Implications in downstream analyses and use. Eur. J. Cell Biol. 101, 151227 (2022).","journal-title":"Eur. J. Cell Biol."},{"key":"1549_CR165","volume":"13","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. Identification of specific markers for human pluripotent stem cell-derived small extracellular vesicles. J Extracell. Vesicles 13, e12409 (2024).","journal-title":"J Extracell. Vesicles"},{"key":"1549_CR166","volume":"11","author":"V Crisostomo","year":"2021","unstructured":"Crisostomo, V. et al. The epicardial delivery of cardiosphere derived cells or their extracellular vesicles is safe but of limited value in experimental infarction. Sci. Rep. 11, 22155 (2021).","journal-title":"Sci. Rep."},{"key":"1549_CR167","volume":"232","author":"Z Wei","year":"2019","unstructured":"Wei, Z. et al. miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury. Life Sci. 232, 116632 (2019).","journal-title":"Life Sci."},{"key":"1549_CR168","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/ejhf.1813","volume":"22","author":"A Garg","year":"2020","unstructured":"Garg, A. et al. MiRNA-181a is a novel regulator of aldosterone-mineralocorticoid receptor-mediated cardiac remodelling. Eur. J. Heart Fail. 22, 1366\u20131377 (2020).","journal-title":"Eur. J. Heart Fail."},{"key":"1549_CR169","volume":"14","author":"J Zhu","year":"2024","unstructured":"Zhu, J. et al. MiR-181a protects the heart against myocardial infarction by regulating mitochondrial fission via targeting programmed cell death protein 4. Sci. Rep. 14, 6638 (2024).","journal-title":"Sci. Rep."},{"key":"1549_CR170","volume":"227","author":"S Mao","year":"2022","unstructured":"Mao, S., Zhao, J., Zhang, Z. J. & Zhao, Q. MiR-183-5p overexpression in bone mesenchymal stem cell-derived exosomes protects against myocardial ischemia\/reperfusion injury by targeting FOXO1. Immunobiology 227, 152204 (2022).","journal-title":"Immunobiology"},{"key":"1549_CR171","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/biof.1571","volume":"46","author":"D Lin","year":"2020","unstructured":"Lin, D., Cui, B., Ma, J. & Ren, J. MiR-183-5p protects rat hearts against myocardial ischemia\/reperfusion injury through targeting VDAC1. Biofactors 46, 83\u201393 (2020).","journal-title":"Biofactors"},{"key":"1549_CR172","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.2147\/IJN.S454277","volume":"19","author":"A Zou","year":"2024","unstructured":"Zou, A. et al. Engineered exosomes with growth differentiation factor-15 overexpression enhance cardiac repair after myocardial injury. Int. J. Nanomed. 19, 3295\u20133314 (2024).","journal-title":"Int. J. Nanomed."},{"key":"1549_CR173","volume":"172","author":"T Xiao","year":"2024","unstructured":"Xiao, T. et al. Extracellular vesicle mediated targeting delivery of growth differentiation factor-15 improves myocardial repair by reprogramming macrophages post myocardial injury. Biomed. Pharmacother. 172, 116224 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"1549_CR174","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63880-5","volume":"14","author":"G Dogon","year":"2024","unstructured":"Dogon, G. et al. Growth\/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration. Sci. Rep. 14, 12949 (2024).","journal-title":"Sci. Rep."},{"key":"1549_CR175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s13287-024-04030-6","volume":"15","author":"X Huang","year":"2024","unstructured":"Huang, X. et al. Pretreatment with growth differentiation factor 15 augments cardioprotection by mesenchymal stem cells in myocardial infarction by improving their survival. Stem Cell Res. Ther. 15, 412 (2024).","journal-title":"Stem Cell Res. Ther."},{"key":"1549_CR176","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijcard.2019.04.088","volume":"292","author":"J Walter","year":"2019","unstructured":"Walter, J. et al. Growth differentiation factor-15 and all-cause mortality in patients with suspected myocardial infarction. Int. J. Cardiol. 292, 241\u2013245 (2019).","journal-title":"Int. J. Cardiol."},{"key":"1549_CR177","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.ajem.2019.04.035","volume":"37","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Zhen, C., Wang, R. & Wang, G. Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: a meta-analysis. Am. J. Emerg. Med. 37, 1346\u20131352 (2019).","journal-title":"Am. J. Emerg. Med."},{"key":"1549_CR178","volume":"9","author":"HJ Park","year":"2023","unstructured":"Park, H. J. et al. Knockdown of deleterious miRNA in progenitor cell-derived small extracellular vesicles enhances tissue repair in myocardial infarction. Sci. Adv. 9, eabo4616 (2023).","journal-title":"Sci. Adv."},{"key":"1549_CR179","doi-asserted-by":"publisher","unstructured":"Li, Q. et al. Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.abb0202 (2021).","DOI":"10.1126\/scitranslmed.abb0202"},{"key":"1549_CR180","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/stmcls\/sxad032","volume":"41","author":"H Shen","year":"2023","unstructured":"Shen, H. & Lane, R. A. Extracellular vesicles from primed adipose-derived stem cells enhance achilles tendon repair by reducing inflammation and promoting intrinsic healing. Stem Cell 41, 617\u2013627 (2023).","journal-title":"Stem Cell"},{"key":"1549_CR181","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jor.24406","volume":"38","author":"H Shen","year":"2020","unstructured":"Shen, H., Yoneda, S., Abu-Amer, Y., Guilak, F. & Gelberman, R. H. Stem cell-derived extracellular vesicles attenuate the early inflammatory response after tendon injury and repair. J. Orthop. Res. 38, 117\u2013127 (2020).","journal-title":"J. Orthop. Res."},{"key":"1549_CR182","doi-asserted-by":"crossref","first-page":"15819","DOI":"10.1073\/pnas.0901216106","volume":"106","author":"G Liu","year":"2009","unstructured":"Liu, G. et al. miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc. Natl Acad. Sci. USA 106, 15819\u201315824 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1549_CR183","doi-asserted-by":"publisher","unstructured":"Rana, N., Suliman, S., Al-Sharabi, N. & Mustafa, K. Extracellular vesicles derived from primed mesenchymal stromal cells loaded on biphasic calcium phosphate biomaterial exhibit enhanced macrophage polarization. Cells https:\/\/doi.org\/10.3390\/cells11030470 (2022).","DOI":"10.3390\/cells11030470"},{"key":"1549_CR184","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1078551","volume":"14","author":"A Hackel","year":"2023","unstructured":"Hackel, A., Vollmer, S., Bruderek, K., Lang, S. & Brandau, S. Immunological priming of mesenchymal stromal\/stem cells and their extracellular vesicles augments their therapeutic benefits in experimental graft-versus-host disease via engagement of PD-1 ligands. Front. Immunol. 14, 1078551 (2023).","journal-title":"Front. Immunol."},{"key":"1549_CR185","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies, L. C., Heldring, N., Kadri, N. & Le Blanc, K. Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells 35, 766\u2013776 (2017).","journal-title":"Stem Cells"},{"key":"1549_CR186","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1007\/s12015-023-10586-2","volume":"19","author":"M Hyland","year":"2023","unstructured":"Hyland, M. et al. Extracellular vesicles derived from umbilical cord mesenchymal stromal cells show enhanced anti-inflammatory properties via upregulation of miRNAs after pro-inflammatory priming. Stem Cell Rev. Rep. 19, 2391\u20132406 (2023).","journal-title":"Stem Cell Rev. Rep."},{"key":"1549_CR187","doi-asserted-by":"publisher","unstructured":"Hyland, M., Mennan, C., Wilson, E., Clayton, A. & Kehoe, O. Pro-inflammatory priming of umbilical cord mesenchymal stromal cells alters the protein cargo of their extracellular vesicles. Cells https:\/\/doi.org\/10.3390\/cells9030726 (2020).","DOI":"10.3390\/cells9030726"},{"key":"1549_CR188","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12085","volume":"10","author":"M Kang","year":"2021","unstructured":"Kang, M., Jordan, V., Blenkiron, C. & Chamley, L. W. Biodistribution of extracellular vesicles following administration into animals: a systematic review. J. Extracell. Vesicles 10, e12085 (2021).","journal-title":"J. Extracell. Vesicles"},{"key":"1549_CR189","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.26316","volume":"4","author":"OP Wiklander","year":"2015","unstructured":"Wiklander, O. P. et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J. Extracell. Vesicles 4, 26316 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"1549_CR190","doi-asserted-by":"crossref","first-page":"e12252","DOI":"10.1371\/journal.pone.0012252","volume":"5","author":"M Zahid","year":"2010","unstructured":"Zahid, M. et al. Identification of a cardiac specific protein transduction domain by in vivo biopanning using a M13 phage peptide display library in mice. PLoS ONE 5, e12252 (2010).","journal-title":"PLoS ONE"},{"key":"1549_CR191","doi-asserted-by":"publisher","unstructured":"Sahagun, D. & Zahid, M. Cardiac-targeting peptide: from discovery to applications. Biomolecules https:\/\/doi.org\/10.3390\/biom13121690 (2023).","DOI":"10.3390\/biom13121690"},{"key":"1549_CR192","doi-asserted-by":"publisher","unstructured":"Sahagun, D. A., Lopuszynski, J. B., Feldman, K. S., Pogodzinski, N. & Zahid, M. Toxicity studies of cardiac-targeting peptide reveal a robust safety profile. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics16010073 (2024).","DOI":"10.3390\/pharmaceutics16010073"},{"key":"1549_CR193","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bbrc.2018.03.227","volume":"499","author":"H Kim","year":"2018","unstructured":"Kim, H. et al. Cardiac-specific delivery by cardiac tissue-targeting peptide-expressing exosomes. Biochem. Biophys. Res. Commun. 499, 803\u2013808 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1549_CR194","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.omtn.2021.04.018","volume":"24","author":"H Kim","year":"2021","unstructured":"Kim, H. et al. Improved cardiac-specific delivery of RAGE siRNA within small extracellular vesicles engineered to express intense cardiac targeting peptide attenuates myocarditis. Mol. Ther. Nucleic Acids 24, 1024\u20131032 (2021).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1549_CR195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jmb.2004.06.029","volume":"342","author":"MJ McGuire","year":"2004","unstructured":"McGuire, M. J., Samli, K. N., Johnston, S. A. & Brown, K. C. In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo. J. Mol. Biol. 342, 171\u2013182 (2004).","journal-title":"J. Mol. Biol."},{"key":"1549_CR196","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46407-1","volume":"9","author":"KI Mentkowski","year":"2019","unstructured":"Mentkowski, K. I. & Lang, J. K. Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Sci. Rep. 9, 10041 (2019).","journal-title":"Sci. Rep."},{"key":"1549_CR197","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.yjmcc.2011.02.003","volume":"50","author":"S Kanki","year":"2011","unstructured":"Kanki, S. et al. Identification of targeting peptides for ischemic myocardium by in vivo phage display. J. Mol. Cell Cardiol. 50, 841\u2013848 (2011).","journal-title":"J. Mol. Cell Cardiol."},{"key":"1549_CR198","volume":"7","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Engineered exosomes with ischemic myocardium-targeting peptide for targeted therapy in myocardial infarction. J. Am. Heart Assoc. 7, e008737 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"1549_CR199","volume":"11","author":"M Chen","year":"2024","unstructured":"Chen, M. et al. Precision cardiac targeting: empowering curcumin therapy through smart exosome-mediated drug delivery in myocardial infarction. Regen. Biomater. 11, rbad108 (2024).","journal-title":"Regen. Biomater."},{"key":"1549_CR200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62953-9","volume":"14","author":"A Ivanova","year":"2024","unstructured":"Ivanova, A. et al. In vivo phage display identifies novel peptides for cardiac targeting. Sci. Rep. 14, 12177 (2024).","journal-title":"Sci. Rep."},{"key":"1549_CR201","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22126-y","volume":"12","author":"E Bonsergent","year":"2021","unstructured":"Bonsergent, E. et al. Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells. Nat. Commun. 12, 1864 (2021).","journal-title":"Nat. Commun."},{"key":"1549_CR202","doi-asserted-by":"crossref","DOI":"10.1186\/s11671-020-03399-6","volume":"15","author":"BJ Jurgielewicz","year":"2020","unstructured":"Jurgielewicz, B. J., Yao, Y. & Stice, S. L. Kinetics and specificity of HEK293T extracellular vesicle uptake using imaging flow cytometry. Nanoscale Res. Lett. 15, 170 (2020).","journal-title":"Nanoscale Res. Lett."},{"key":"1549_CR203","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-62920-0","volume":"10","author":"P Reclusa","year":"2020","unstructured":"Reclusa, P. et al. Improving extracellular vesicles visualization: from static to motion. Sci. Rep. 10, 6494 (2020).","journal-title":"Sci. Rep."},{"key":"1549_CR204","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110651","volume":"39","author":"K O\u2019Brien","year":"2022","unstructured":"O\u2019Brien, K., Ughetto, S., Mahjoum, S., Nair, A. V. & Breakefield, X. O. Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo. Cell Rep. 39, 110651 (2022).","journal-title":"Cell Rep."},{"key":"1549_CR205","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1021\/acsnano.9b10033","volume":"14","author":"BS Joshi","year":"2020","unstructured":"Joshi, B. S., de Beer, M. A., Giepmans, B. N. G. & Zuhorn, I. S. Endocytosis of extracellular vesicles and release of their cargo from endosomes. ACS Nano 14, 4444\u20134455 (2020).","journal-title":"ACS Nano"},{"key":"1549_CR206","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fphar.2020.00697","volume":"11","author":"J Xie","year":"2020","unstructured":"Xie, J. et al. Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application. Front. Pharmacol. 11, 697 (2020).","journal-title":"Front. Pharmacol."},{"key":"1549_CR207","doi-asserted-by":"crossref","DOI":"10.1038\/srep34937","volume":"6","author":"I Nakase","year":"2016","unstructured":"Nakase, I., Noguchi, K., Fujii, I. & Futaki, S. Vectorization of biomacromolecules into cells using extracellular vesicles with enhanced internalization induced by macropinocytosis. Sci. Rep. 6, 34937 (2016).","journal-title":"Sci. Rep."},{"key":"1549_CR208","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02014-6","volume":"7","author":"I Nakase","year":"2017","unstructured":"Nakase, I. et al. Arginine-rich cell-penetrating peptide-modified extracellular vesicles for active macropinocytosis induction and efficient intracellular delivery. Sci. Rep. 7, 1991 (2017).","journal-title":"Sci. Rep."},{"key":"1549_CR209","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1021\/acs.molpharmaceut.1c00882","volume":"19","author":"S Hirase","year":"2022","unstructured":"Hirase, S. et al. Dodecaborate-encapsulated extracellular vesicles with modification of cell-penetrating peptides for enhancing macropinocytotic cellular uptake and biological activity in boron neutron capture therapy. Mol. Pharm. 19, 1135\u20131145 (2022).","journal-title":"Mol. Pharm."},{"key":"1549_CR210","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00216-025-05742-1","volume":"417","author":"J Zhang","year":"2025","unstructured":"Zhang, J. et al. An effective cell-penetrating peptide-based loading method to extracellular vesicles and enhancement in cellular delivery of drugs. Anal. Bioanal. Chem. 417, 1449\u20131459 (2025).","journal-title":"Anal. Bioanal. Chem."},{"key":"1549_CR211","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2016.01.009","volume":"224","author":"SAA Kooijmans","year":"2016","unstructured":"Kooijmans, S. A. A. et al. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time. J. Control Release 224, 77\u201385 (2016).","journal-title":"J. Control Release"},{"key":"1549_CR212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2021.2003656","volume":"23","author":"L Patras","year":"2022","unstructured":"Patras, L. et al. Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo. Cancer Biol. Ther. 23, 1\u201316 (2022).","journal-title":"Cancer Biol. Ther."},{"key":"1549_CR213","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.hlc.2022.12.015","volume":"32","author":"Y Cao","year":"2023","unstructured":"Cao, Y. et al. New drug targets and preclinical modelling recommendations for treating acute myocardial infarction. Heart Lung Circ. 32, 852\u2013869 (2023).","journal-title":"Heart Lung Circ."},{"key":"1549_CR214","doi-asserted-by":"publisher","unstructured":"Cox, F. F. et al. Protective effects of curcumin in cardiovascular diseases-impact on oxidative stress and mitochondria. Cells https:\/\/doi.org\/10.3390\/cells11030342 (2022).","DOI":"10.3390\/cells11030342"},{"key":"1549_CR215","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1476-5381.2012.02109.x","volume":"167","author":"NP Wang","year":"2012","unstructured":"Wang, N. P., Wang, Z. F., Tootle, S., Philip, T. & Zhao, Z. Q. Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction. Br. J. Pharmacol. 167, 1550\u20131562 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"1549_CR216","first-page":"1267","volume":"10","author":"J Xiao","year":"2016","unstructured":"Xiao, J., Sheng, X., Zhang, X., Guo, M. & Ji, X. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Des. Devel. Ther. 10, 1267\u20131277 (2016).","journal-title":"Drug Des. Devel. Ther."},{"key":"1549_CR217","doi-asserted-by":"publisher","unstructured":"Bertoncini-Silva, C. et al. Enhancing the bioavailability and bioactivity of curcumin for disease prevention and treatment. Antioxidants https:\/\/doi.org\/10.3390\/antiox13030331 (2024).","DOI":"10.3390\/antiox13030331"},{"key":"1549_CR218","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/mt.2010.105","volume":"18","author":"D Sun","year":"2010","unstructured":"Sun, D. et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol. Ther. 18, 1606\u20131614 (2010).","journal-title":"Mol. Ther."},{"key":"1549_CR219","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2021.01.018","volume":"331","author":"JY Kang","year":"2021","unstructured":"Kang, J. Y., Kim, H., Mun, D., Yun, N. & Joung, B. Co-delivery of curcumin and miRNA-144-3p using heart-targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction. J. Control Release 331, 62\u201373 (2021).","journal-title":"J. Control Release"},{"key":"1549_CR220","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1425159","volume":"11","author":"D Bernath-Nagy","year":"2024","unstructured":"Bernath-Nagy, D. et al. Circulating extracellular vesicles as biomarkers in the diagnosis, prognosis and therapy of cardiovascular diseases. Front. Cardiovasc. Med. 11, 1425159 (2024).","journal-title":"Front. Cardiovasc. Med."},{"key":"1549_CR221","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.trecan.2022.05.002","volume":"8","author":"K Jerabkova-Roda","year":"2022","unstructured":"Jerabkova-Roda, K., Dupas, A., Osmani, N., Hyenne, V. & Goetz, J. G. Circulating extracellular vesicles and tumor cells: sticky partners in metastasis. Trends Cancer 8, 799\u2013805 (2022).","journal-title":"Trends Cancer"},{"key":"1549_CR222","doi-asserted-by":"crossref","first-page":"98","DOI":"10.21037\/sci.2017.12.03","volume":"4","author":"PD Robbins","year":"2017","unstructured":"Robbins, P. D. Extracellular vesicles and aging. Stem Cell Investig. 4, 98 (2017).","journal-title":"Stem Cell Investig."},{"key":"1549_CR223","doi-asserted-by":"crossref","first-page":"923","DOI":"10.4049\/jimmunol.2400335","volume":"213","author":"TL Whiteside","year":"2024","unstructured":"Whiteside, T. L. Tumor-derived exosomes and antitumor immunity. J. Immunol. 213, 923\u2013931 (2024).","journal-title":"J. Immunol."},{"key":"1549_CR224","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101250","volume":"32","author":"J Dias","year":"2024","unstructured":"Dias, J., Garcia, J., Agliardi, G. & Roddie, C. CAR-T cell manufacturing landscape\u2014lessons from the past decade and considerations for early clinical development. Mol. Ther. Methods Clin. Dev. 32, 101250 (2024).","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01549-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01549-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01549-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:04:28Z","timestamp":1762297468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01549-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":224,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["1549"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01549-3","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}